X

Health Care

Sunesis Pharmaceutical (SNSS): Q4 2019 Earnings Snapshot

Image for representation (Photo by Drew Hays on Unsplash) — Sunesis Pharmaceuticals (NASDAQ: SNSS) reported loss of $0.05 per share in the…

Catabasis Pharmaceuticals (NASDAQ: CATB): Q4 2019 Earnings Snapshot

-- Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) reported a net loss of $6.6 million or $0.55 per share for the fourth…

InspireMD misses Q4 revenue estimates

InspireMD Inc. (NYSE: NSPR) reported earnings that matched expectations for the fourth quarter of 2019 while revenues missed estimates. The…

Akebia Therapeutics (AKBA) Q4 2019 Earnings Snapshot

-- Akebia Therapeutics (NASDAQ: AKBA) reported fourth quarter 2019 loss of $0.79 per share vs. expected loss of $0.47 per…

Minerva Neurosciences (NASDAQ: NERV): Q4 2019 Earnings Snapshot

-- Minerva Neurosciences Inc. (NASDAQ: NERV) reported a fourth-quarter 2019 loss of $29.9 million or $0.77 per share, wider than…

BioXcel Therapeutics (BTAI) Q4 loss widens on higher expenses

BioXcel Therapeutics, Inc. (NASDAQ: BTAI) reported a wider net loss for the fourth quarter, owing to an increase in research…

Matinas BioPharma (MTNB): Q4 2019 Earnings Snapshot

Image for representation (Photo by Drew Hays on Unsplash) — Matinas BioPharma (NYSE: MTNB) reported loss of $0.04 per share in the…

No surprises expected when InspireMD (NSPR) reports Q4 earnings

InspireMD (NYSE: NSPR) has incurred losses consistently over the past several years. Of late, shareholders have been apprehensive about their…

Bio-Path Holdings (NASDAQ: BPTH): 2019 Earnings Snapshot

-- Bio-Path Holdings Inc. (NASDAQ: BPTH) reported a loss of $3.24 share for the full year 2019, narrower than a…

Aurinia Pharmaceuticals (NASDAQ: AUPH): Q4 2019 Earnings Snapshot

-- Aurinia Pharmaceuticals (NASDAQ: AUPH) reported a fourth-quarter 2019 loss of $0.78 per share versus a loss of $0.14 per…